Stephanie Kjærulff Holm

Stephanie Kjærulff Holm

PhD fellow, Ph.d.-fellow

Member of:


    Publication year:
    1. 2022
    2. Published

      Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2

      Holm, Stephanie Kjærulff, Husted, Anna Sofie, Skov, Louise Julie, Morville, T. H., Hagemann, C. A., Jorsal, T., Dall, M., Jakobsen, A., Klein, A. B., Treebak, Jonas Thue, Knop, Filip Krag, Schwartz, Thue W., Clemmensen, Christoffer & Holst, Birgitte, 2022, In: Endocrinology. 163, 6, 13 p., bqac038.

      Research output: Contribution to journalJournal articlepeer-review

    3. Published
    4. 2021
    5. Published

      Exogenous LEAP2 improves postprandial glucose tolerance and reduces ad libitum food intake in men

      Hagemann, C. A., Jensen, M. S., Holm, Stephanie Kjærulff, Gasbjerg, Lærke Smidt, Christensen, Mikkel Bring, Heimburger, S. M. N., Dela, Flemming, Vilsbøll, Tina, Holst, Birgitte & Knop, Filip Krag, 2021, In: Diabetologia. 64, SUPPL 1, p. 23-23 1 p.

      Research output: Contribution to journalConference abstract in journalpeer-review

    6. Published

      Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 Fragment

      Hagemann, C. A., Zhang, C., Hansen, H. H., Jorsal, T., Rigbolt, K. T. G., Madsen, M. R., Bergmann, N. C., Heimbürger, S. M. N., Falkenhahn, M., Theis, S., Breitschopf, K., Holm, Stephanie Kjærulff, Hedegaard, M. A., Christensen, Mikkel Bring, Vilsbøll, Tina, Holst, Birgitte, Vrang, N., Jelsing, J. & Knop, Filip Krag, 2021, In: The Journal of clinical endocrinology and metabolism. 106, 2, p. e966-e981

      Research output: Contribution to journalJournal articlepeer-review

    ID: 250853938